A Gaithersburg biopharmaceutical company has raised $23 million in Series A financing, the company announced Tuesday. NexImmune raised the money in a round co-led by ArrowMark Partners and Barer & Son, along with participation from Piedmont Capital Partners. ArrowMark is ...
Tagged with: biopharmaceutical funding NexImmune series A
Read More »